Published in Clin Exp Allergy on December 01, 2010
Lactobacillus Rhamnosus GG: Interaction With Human Microbiota and Immunity | NCT01148667
Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease. Microb Cell Fact (2013) 1.14
Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk for atopic disease. BMC Microbiol (2013) 1.10
The Potential Therapeutic Efficacy of Lactobacillus GG in Children with Food Allergies. Pharmaceuticals (Basel) (2012) 0.89
Gut microbiota as potential therapeutic target for the treatment of cow's milk allergy. Nutrients (2013) 0.85
Perinatal pet exposure, faecal microbiota, and wheezy bronchitis: is there a connection? ISRN Allergy (2013) 0.83
Immunoregulatory potential of exopolysaccharide from Lactobacillus rhamnosus KL37: effects on the production of inflammatory mediators by mouse macrophages. Int J Exp Pathol (2011) 0.79
Probiotics and atopic dermatitis in children. Pharmaceuticals (Basel) (2012) 0.79
Effect of type of TAG fatty acids on lutein and zeaxanthin bioavailability. Br J Nutr (2012) 0.79
Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of Probiotics. PLoS One (2015) 0.78
Effects of probiotics on the prevention of atopic dermatitis. Korean J Pediatr (2012) 0.78
Prevention and Management of Cow's Milk Allergy in Non-Exclusively Breastfed Infants. Nutrients (2017) 0.76
The Early Intestinal Microbiota of Healthy Korean Newborns. Iran J Pediatr (2015) 0.75
The Variable Regions of Lactobacillus rhamnosus Genomes Reveal the Dynamic Evolution of Metabolic and Host-Adaptation Repertoires. Genome Biol Evol (2016) 0.75
Coriander alleviates 2,4-dinitrochlorobenzene-induced contact dermatitis-like skin lesions in mice. J Med Food (2014) 0.75
Long-term safety assessment in children who received hydrolyzed protein formulas with Lactobacillus rhamnosus GG: a 5-year follow-up. Eur J Pediatr (2016) 0.75
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet (2001) 6.82
Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol (2001) 3.61
Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet (1984) 3.55
Functional food science and gastrointestinal physiology and function. Br J Nutr (1998) 2.78
Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci (1992) 2.78
Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics (1999) 2.45
Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr (1995) 2.30
Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol (1997) 2.26
Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet (1983) 2.20
Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res (1992) 2.17
Probiotics: effects on immunity. Am J Clin Nutr (2001) 2.10
Probiotics in the management of atopic eczema. Clin Exp Allergy (2000) 2.00
Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study. J Allergy Clin Immunol (2001) 1.93
Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med (1990) 1.90
Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie Van Leeuwenhoek (1996) 1.86
Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr (1997) 1.80
Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin Exp Allergy (2008) 1.79
Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut (2002) 1.74
Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr (1985) 1.73
Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months. Arch Dis Child Fetal Neonatal Ed (2000) 1.68
The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol Lett (1998) 1.62
Influence of mode of delivery on gut microbiota composition in seven year old children. Gut (2004) 1.55
Prevention of travellers' diarrhoea by Lactobacillus GG. Ann Med (1990) 1.54
Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab (1996) 1.53
Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy (2000) 1.53
Ability of dairy strains of lactic acid bacteria to bind a common food carcinogen, aflatoxin B1. Food Chem Toxicol (1998) 1.52
Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy (2007) 1.49
Polyunsaturated fatty acids in maternal diet, breast milk, and serum lipid fatty acids of infants in relation to atopy. Allergy (2001) 1.47
Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers. Int J Food Microbiol (1995) 1.46
Probiotics: a role in the treatment of intestinal infection and inflammation? Gut (2002) 1.46
Probiotics demonstrating efficacy in clinical settings. Clin Infect Dis (2001) 1.46
Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child (1995) 1.38
Surface binding of aflatoxin B(1) by lactic acid bacteria. Appl Environ Microbiol (2001) 1.37
Quality assurance criteria for probiotic bacteria. Am J Clin Nutr (2001) 1.37
The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes (Lond) (2010) 1.31
Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol (2001) 1.30
A comparative trial of rapid oral and intravenous rehydration in acute diarrhoea. Acta Paediatr Scand (1987) 1.27
Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci (1994) 1.27
Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin Diagn Lab Immunol (2001) 1.24
Milk versus no milk in rapid refeeding after acute gastroenteritis. J Pediatr Gastroenterol Nutr (1986) 1.22
Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria. Appl Environ Microbiol (2000) 1.21
Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett Appl Microbiol (2007) 1.20
Bifidobacterium and Lactobacillus DNA in the human placenta. Lett Appl Microbiol (2008) 1.19
Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol (2001) 1.19
Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin Exp Allergy (1998) 1.18
Guidelines prepared by the ESPGAN Working Group on Acute Diarrhoea. Recommendations for feeding in childhood gastroenteritis. European Society of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr (1997) 1.16
Nutrition economics - characterising the economic and health impact of nutrition. Br J Nutr (2010) 1.14
Ability of Lactobacillus and Propionibacterium strains to remove aflatoxin B, from the chicken duodenum. J Food Prot (2000) 1.14
Transforming growth factor-beta in breast milk: a potential regulator of atopic disease at an early age. J Allergy Clin Immunol (1999) 1.13
Age-dependent variation in the serum concentration of mannan-binding protein. Acta Paediatr (1996) 1.12
Physicochemical alterations enhance the ability of dairy strains of lactic acid bacteria to remove aflatoxin from contaminated media. J Food Prot (1998) 1.11
Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr (1994) 1.10
Active immunity is seen as a reduction in the cell response to oral live vaccine. Vaccine (1991) 1.10
Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am J Gastroenterol (1997) 1.10
Glutamate decarboxylase-reactive peripheral blood lymphocytes from patients with IDDM express gut-specific homing receptor alpha4beta7-integrin. Diabetes (1997) 1.08
Ability of dairy strains of lactic acid bacteria to bind aflatoxin M1 in a food model. J Food Prot (2000) 1.07
Lactobacilli and bacteremia in southern Finland, 1989-1992. Clin Infect Dis (1996) 1.07
A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea. Acta Paediatr (1997) 1.06
The allergy epidemic extends beyond the past few decades. Clin Exp Allergy (2004) 1.06
Aflatoxin B1 binding by dairy strains of lactic acid bacteria and bifidobacteria. J Dairy Sci (2001) 1.04
Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol (2001) 1.04
Permanent colonization by Lactobacillus casei is hindered by the low rate of cell division in mouse gut. Appl Environ Microbiol (2004) 1.03
Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol (1988) 1.03
Gut bacteria and health foods--the European perspective. Int J Food Microbiol (2002) 1.02
Removal of common Fusarium toxins in vitro by strains of Lactobacillus and Propionibacterium. Food Addit Contam (2002) 1.02
Homing potentials of circulating antibody-secreting cells after administration of oral or parenteral protein or polysaccharide vaccine in humans. Vaccine (1999) 1.02
Pandemic of atopic diseases--a lack of microbial exposure in early infancy? Curr Drug Targets Infect Disord (2002) 1.00
A multicentre study on behalf of the European Society of Paediatric Gastroenterology and Nutrition Working Group on Acute Diarrhoea. Early feeding in childhood gastroenteritis. J Pediatr Gastroenterol Nutr (1997) 0.98
Lactobacillus crispatus and its nonaggregating mutant in human colonization trials. J Dairy Sci (2001) 0.98
The influence of polyunsaturated fatty acids on probiotic growth and adhesion. FEMS Microbiol Lett (2001) 0.98
Prospective, controlled, multi-center study on the effect of an amino-acid-based formula in infants with cow's milk allergy/intolerance and atopic dermatitis. Pediatr Allergy Immunol (2001) 0.97
Neonatal septicaemia in Finland 1981-85. Predominance of group B streptococcal infections with very early onset. Acta Paediatr Scand (1989) 0.97
Assessment of adhesion properties of novel probiotic strains to human intestinal mucus. Int J Food Microbiol (2001) 0.97
Evaluation of the gut mucosal barrier: evidence for increased antigen transfer in children with atopic eczema. J Allergy Clin Immunol (1996) 0.97
A consensus protocol for the determination of the threshold doses for allergenic foods: how much is too much? Clin Exp Allergy (2004) 0.96
Adhesion of inactivated probiotic strains to intestinal mucus. Lett Appl Microbiol (2000) 0.96
Comparison of the human immune response to live oral, killed oral or killed parenteral Salmonella typhi TY21A vaccines. Microb Pathog (1991) 0.96
Differences in composition and mucosal adhesion of bifidobacteria isolated from healthy adults and healthy seniors. Curr Microbiol (2001) 0.96
Microbial interactions to intestinal mucosal models. Methods Enzymol (2001) 0.96
Effects of polyunsaturated fatty acids in growth medium on lipid composition and on physicochemical surface properties of lactobacilli. Appl Environ Microbiol (2004) 0.96
Gut flora in normal and disordered states. Chemotherapy (1995) 0.95
Glycine supplemented oral rehydration solutions for diarrhoea. Arch Dis Child (1986) 0.95
Safety of probiotic bacteria. Asia Pac J Clin Nutr (1996) 0.95
Intestinal inflammation in children with atopic eczema: faecal eosinophil cationic protein and tumour necrosis factor-alpha as non-invasive indicators of food allergy. Clin Exp Allergy (1996) 0.95
Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG-derived enzymes. J Allergy Clin Immunol (1996) 0.94
Differences in the gut bacterial flora of healthy and milk-hypersensitive adults, as measured by fluorescence in situ hybridization. FEMS Immunol Med Microbiol (2001) 0.94
Fermented cereal with specific bifidobacteria normalizes bowel movements in elderly nursing home residents. A randomized, controlled trial. J Nutr Health Aging (2007) 0.94